Publications by authors named "Louis Nabors"

Claim this Profile
"
"Successful use of response leads to ONC201 approval".
Louis Burt Nabors

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting pseudo versus true progression of glioblastoma via accurate quantitative DCE-MRI using point-of-care portable perfusion phantoms: a pilot study.
Martin Holland, Chetana Krishnan, Houman Sotoudeh, Louis Nabors, John Fiveash

Quant Imaging Med Surg· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN CNS Tumor Guidelines Update for 2024.
Louis Burt Nabors, Jona Hattangadi-Gluth, Craig Horbinski, Jana Portnow

Neuro Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma.
Eudocia Q Lee, Brian M Alexander, Carlos G Romo, Jeffrey G Supko, Nathalie Y R Agar, Louis B Nabors

Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A window-of-opportunity trial reveals mechanisms of response and resistance to navtemadlin in patients with recurrent glioblastoma.
Veronica Rendo, Eudocia Q Lee, Connor Bossi, Nicholas Khuu, Michelle A Rudek, Louis B Nabors

Sci Transl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Screening of TREM1 Inhibitors in Cell-Based Reporter Assays Reflecting TREM1/DAP12 Receptor Assembly and Functionality.
Natalia Filippova, Roman Hromov, James Shi, Peter H King, Louis B Nabors

ACS Chem Neurosci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Planned Glucarpidase Allows Safe Outpatient High-Dose Methotrexate Treatment for CNS Lymphoma.
Lauren R Schaff, Dean Carlow, Ryan Schofield, Venissala Wongchai, Juli Madzsar, Louis B Nabors

JCO Oncol Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma.
Veronica Rendo, Eudocia Q Lee, Connor Bossi, Nicholas Khuu, Michelle A Rudek, Louis B Nabors

medRxiv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma.
Karisa C Schreck, Roy E Strowd, Louis B Nabors, Benjamin M Ellingson, Michael Chang

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702.
John B Fiveash, Xiaobu Ye, David M Peerboom, Tom Mikkelsen, Sajeel Chowdhary, Louis B Nabors

PLoS One· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 trial of TPI 287, a microtubule stabilizing agent, in combination with bevacizumab in adults with recurrent glioblastoma.
Samuel A Goldlust, Louis B Nabors, Sigmund Hsu, Nimish Mohile, Paul J Duic

Neurooncol Adv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An expanded safety/feasibility study of the EMulate Therapeutics Voyager™ System in patients with recurrent glioblastoma.
Garni Barkhoudarian, Michael Badruddoja, Nicholas Blondin, Sajeel Chowdhary, Charles Cobbs, Louis Burt Nabors

CNS Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Craig Horbinski, Louis Burt Nabors, Jana Portnow, Joachim Baehring, Ankush Bhatia

J Natl Compr Canc Netw· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma.
Dahye Park, Mina Lobbous, Louis B Nabors, James M Markert, Jinsuh Kim

CNS Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement.
Stephen J Bagley, Shawn Kothari, Rifaquat Rahman, Eudocia Q Lee, Gavin P Dunn, Louis Burt Nabors

Clin Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack.
Abhishek Guha, Saboora Waris, Louis B Nabors, Natalia Filippova, Myriam Gorospe

Adv Drug Deliv Rev· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal platform for assessing drug distribution and response in clinical trials.
Begoña G C Lopez, Ishwar N Kohale, Ziming Du, Ilya Korsunsky, Walid M Abdelmoula, Louis B Nabors

Neuro Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SRI-42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide-induced neuroinflammation.
Rajeshwari Chellappan, Abhishek Guha, Ying Si, Thaddaeus Kwan, Louis B Nabors

Glia· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.
Lauren R Schaff, Mina Lobbous, Dean Carlow, Ryan Schofield, Igor T Gavrilovic, Louis B Nabors

BMC Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial.
Corinne E Griguer, Claudia R Oliva, Christopher S Coffey, Merit E Cudkowicz, Robin A Conwit, Louis B Nabors

Neurooncol Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors.
Natalia Filippova, Xiuhua Yang, Subramaniam Ananthan, Jennifer Calano, Vibha Pathak, Louis B Nabors

Cancer Res· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central Nervous System Cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Louis Burt Nabors, Jana Portnow, Manmeet Ahluwalia, Joachim Baehring, Henry Brem

J Natl Compr Canc Netw· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity.
Natalia Filippova, Louis B Nabors

Cancers (Basel)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy.
Soniya Bastola, Marat S Pavlyukov, Daisuke Yamashita, Sadashib Ghosh, Heejin Cho, Louis B Nabors

Nat Commun· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.
Merit Cudkowicz, Marianne K Chase, Christopher S Coffey, Dixie J Ecklund, Brenda J Thornell, Louis B Nabors

JAMA Neurol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis